iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Natco Pharma consolidated net profit declines 12.75% in the September 2022 quarter

10 Nov 2022 , 03:43 PM

Net profit of Natco Pharma declined 12.75% to Rs 56.80 crore in the quarter ended September 2022 as against Rs 65.10 crore during the previous quarter ended September 2021. Sales rose 14.55% to Rs 432.10 crore in the quarter ended September 2022 as against Rs 377.20 crore during the previous quarter ended September 2021.

Particulars Quarter Ended
? Sep. 2022 Sep. 2021 % Var.
Sales 432.10 377.20 15
OPM % 22.06 18.69
PBDT 112.00 104.50 7
PBT 70.30 69.80 1
NP 56.80 65.10 -13

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.